Edwards Lifesciences (EW) is the global leader in patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences Taiwan would like to take the initiative to build a platform to share experiences and roadmaps of innovation in the medical device industry.
The goals are to explore new opportunities for Taiwan Biotech to innovate in the space of interventional cardiac and endovascular therapies, to bridge the cross-industry cooperation with outstanding Taiwanese companies and to inspire Taiwanese young talents to devote their careers in MEDTECH.
It is our great honor to invite Dr. Ming H. Wu, Vice President Engineering at Edwards Lifesciences and Executive Director of The BioMed Commercialization Center-Med Tech to be our keynote speakers of Edwards Taiwan US MedTech Symposium.
Date: Mar 28, 2019 (Thur)
Venue: Regent Taipei (No. 3, Ln. 39, Sec. 2 Zhongshan N. Rd., Taipei 104, Taiwan)